In addition, the gene expression-based genome-wide association study (eGWAS), conducted across 130 separate experiments (a total of 1175 T2D case-control microarrays) to determine additional genes that are functionally associated with the molecular pathogenesis of T2D, identified CD44 as another leading candidate (P = 8.5 × 10−20) [96]. This evidence concerns the gene CD44 and type 2 diabetes mellitus.